Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
0.7050
-0.0712 (-9.17%)
May 5, 2025, 4:00 PM EDT - Market closed
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $114.03 million as of May 5, 2025. Its market cap has decreased by -93.15% in one year.
Market Cap
114.03M
Enterprise Value
-192.89M
1-Year Change
-93.15%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $114.03M, a decrease of -95.59%. That is a compound annual growth rate of -85.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 125.55M | -92.67% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |